Contact

Flashwave®

Max-Stromeyer-Str. 116

78467 Konstanz, Germany

UROGENITAL DISEASES


Flashwave® technology is highly effective across the board of a wide range of medical applications, utilizing Biocellular Transductive Wave Therapy.


As such Flashwave® is a new and innovative treatment option for urogenital diseases, such as

  • Erectile Dysfunction (ED) of vascular origin

  • Induratio Penis Plastic (IPP)

  • Nonbacterial Prostatitis

  • Chronic Pelvic Pain Syndrome (CPPS)

With the unique Flashwave® technology even deep-lying areas can be treated easily, it’s bespoke urology CCI allowing easy access, a high degree of accuracy and short treatment time, as Flashwave® only has to be applied to one side of the penis or the crus.

For treatment of urogenital indications Flashwave® focuses on blood vessels and encouraging neovascularization in the penis shaft and crus, helping relieve vascular deficiency, a common cause of, among other things, erectile dysfunction.

Erectile Dysfunction (ED)


Erectile dysfunction (ED) is a sexual dysfunction that is increasingly prevalent with age. Men affected by ED are unable to develop or maintain an erection sufficient for sexual intercourse despite being sexually stimulated. Most ED cases are of vascular origin.


Unlike conventional ED treatment, such as PDE-5 inhibitors, Flashwave® does not involve the use of any pharmaceuticals. The non-invasive Flashwave® procedure is performed during a series of five treatments and requires no sedation or anesthesia.
Noticeable improvement may be visible within two weeks after start of the therapy. A high rate of patient satisfaction can be observed, all without reliance on PDE-5 inhibitors or antibiotics.
Flashwave® has also shown significant longterm effectiveness.


Vasculogenic and diabetic ED patients will benefit from Flashwave® – those who are responsive to PDE-5 inhibitors as well as those who are unresponsive.
For the latter group, which includes a substantial number of severe ED patients, the only solution to date are vacuum pumps, injections and perhaps implants. Flashwave® therapy not only offers a new treatment option, but brings hope to those patients, by allowing more than 70 % of them to become responsive to PDE-5 inhibitors. As »end-stage« ED patients, they will be able to enjoy normal sexual functionality. With over 50 % of men aged 40–70 suffering from ED, and even more from transient ED, Flashwave® therapy can bring improvement in erectile function and new sexual spontaneity to millions of patients – in a safe and natural manner.

  • We recommend one treatment per week over a duration of 5 weeks.

  • If necessary, the treatment cycle can be repeated 8 weeks after the last treatment.

  • Based on cellular communication – triggers the body’s natural repair mechanism.

 

Induratio Penis Plastica (IPP)


Induratio penis plastica (IPP), also known as Peyronie’s disease, is an acquired and generally progressive condition of the penis. The majority of patients notice the presence of the disease when they feel thickened nodules (so-called plaques) under the skin of the penis. As the disease progresses, pain may occur with or without an erection and the penis becomes curved during an erection, which can make it difficult or impossible to have sexual intercourse.

  • We recommend one treatment per week over a duration of five weeks.

  • Flashwave® is applied on each area affected by plaque during a treatment session.

  • If necessary, the treatment cycle can be repeated 8 weeks after the last treatment.

  • Based on cellular communication –  triggers the body’s natural repair mechanism.

 

Nonbacterial Prostatitis


Nonbacterial prostatitis refers to a condition that affects patients who show symptoms of prostatitis but without a positive result on culture of urine or expressed prostate secretions (EPS).
Traditional treatment of chronic nonbacterial prostatitis (IIIa and IIIb) was with treatment  for 4–6 weeks.

  • Flashwave® modulates the inflammation cascade, significantly reducing pain sensations even after the first treatment.

  • We recommend one treatment per week over a duration of 5 weeks.

  • Flashwave® is applied directly on the pelvic floor muscle.

  • If necessary, the treatment cycle can be repeated 8 weeks after the last treatment.

  • Based on cellular communication –  triggers the body’s natural repair mechanism.

 

Chronic Pelvic Pain Syndrome (CPPS)


Chronic pelvic pain syndrome (CPPS) is characterized by pain in the region of the pelvic floor.
Further symptoms are micturition problems without evidence of urinary tract infection. Some patients may also experience erectile dysfunction.

  • We recommend one treatment per week over a duration of 5 weeks.

  • Flashwave® is applied directly on the pelvic floor muscle.

  • If necessary, the treatment cycle can be repeated 8 weeks after the last treatment.

  • Based on cellular communication – triggers the body’s natural repair mechanism.